Joe Schroers-Martin, MD

an assistant professor of medicine in the Division of Oncology

Stanford University School of Medicine

Published Articles (1)

Novel Agents and MRD-Guided Therapy Are Reshaping Frontline Lymphoma Care

September 21, 2026

Bruton's tyrosine kinase (BTK) inhibitor combinations now anchor frontline mantle cell lymphoma treatment across age and fitness categories, including chemotherapy-free regimens for older patients and TP53-mutated disease.